We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
91 hedge funds and large institutions have $150M invested in Lexicon Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
77% more call options, than puts
Call options by funds: $288K | Put options by funds: $163K
16% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 25
2.88% less ownership
Funds ownership: 100.21% → 97.33% (-2.9%)
16% less funds holding
Funds holding: 108 → 91 (-17)
30% less capital invested
Capital invested by funds: $214M → $150M (-$64M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
71% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 24
Holders
91
Holders Change
-17
Holders Change %
-15.74%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
7
Increased
29
Reduced
25
Closed
24
Calls
$288K
Puts
$163K
Net Calls
+$125K
Net Calls Change
+$25K
Top Buyers
| 1 |
Lazard Asset Management
New York
|
+$1.78M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.07M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$875K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$650K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$594K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.09M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$1.17M |
| 3 |
Morgan Stanley
New York
|
-$1.12M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1M |
| 5 |
Two Sigma Advisers
New York
|
-$909K |
